Advances in the clinical use of collagen as biomarker of liver fibrosis

References

• Hynes RO, Naba A Overview of the matrisome–an inventory of extracellular matrix constituents and functions. Cold Spring Harb Perspect Biol. 2012;4(1):a004903.
   PubMed Web of Science ®Google Scholar
• Naba A, Clauser KR, Hoersch S, et al. The matrisome: In silico definition and in vivo characterization by proteomics of normal and tumor extracellular matrices. Mol Cell Proteomics 2012;11(4):M111.014647.
   PubMed Web of Science ®Google Scholar
• Ott HC, Matthiesen TS, Goh SK, et al. Perfusion-decellularized matrix: Using nature’s platform to engineer a bioartificial heart. Nat Med. 2008;14(2):213–221.
   PubMed Web of Science ®Google Scholar
• Croce S, Peloso A, Zoro T, et al. A hepatic scaffold from decellularized liver tissue: Food for thought. Biomolecules 2019;9(12). pii: E813.
   PubMed Web of Science ®Google Scholar
• Sellaro TL, Ravindra AK, Stolz DB, et al. Maintenance of hepatic sinusoidal endothelial cell phenotype in vitro using organ-specific extracellular matrix scaffolds. Tissue Eng. 2007;13(9):2301–2310.
   PubMedGoogle Scholar
• Robertson IB, Rifkin DB Regulation of the bioavailability of TGF-β and TGF-β-related proteins. Cold Spring Harb Perspect Biol. 2016;8(6). pii: a021907.
   PubMed Web of Science ®Google Scholar
• Hynes RO Integrins: Bidirectional, allosteric signaling machines. Cell 2002;110(6):673–687.
   PubMed Web of Science ®Google Scholar
• Huang H, Wright S, Zhang J, et al. Getting a grip on adhesion: Cadherin switching and collagen signaling. Biochim Biophys Acta Mol Cell Res. 2019;1866(11):118472.
   PubMed Web of Science ®Google Scholar
• Munger JS, Huang X, Kawakatsu H, et al. The integrin alpha v beta 6 binds and activates latent TGF β 1: A mechanism for regulating pulmonary inflammation and fibrosis. Cell 1999;96(3):319–328.
   PubMed Web of Science ®Google Scholar
• Annes JP, Rifkin DB, Munger JS The integrin αVβ6 binds and activates latent TGFβ3. FEBS Lett. 2002;511(1–3):65–68.
   PubMed Web of Science ®Google Scholar
• Mu D, Cambier S, Fjellbirkeland L, et al. The integrin alpha(v)beta8 mediates epithelial homeostasis through MT1-MMP-dependent activation of TGF-β1. J Cell Biol. 2002;157(3):493–507.
   PubMed Web of Science ®Google Scholar
• Hastings JF, Skhinas JN, Fey D, et al. The extracellular matrix as a key regulator of intracellular signalling networks. Br J Pharmacol. 2019;176(1):82–92.
   PubMed Web of Science ®Google Scholar
• Massey VL, Dolin CE, Poole LG, et al. The hepatic “matrisome” responds dynamically to injury: Characterization of transitional changes to the extracellular matrix in mice. Hepatology. 2017;65(3):969–982.
   PubMed Web of Science ®Google Scholar
• Weiskirchen R, Weiskirchen S, Tacke F Recent advances in understanding liver fibrosis: Bridging basic science and individualized treatment concepts. F1000Res.2018;7. pii: F1000 Faculty Rev–921.
   PubMedGoogle Scholar
• Weiskirchen R, Weiskirchen S, Tacke F Organ and tissue fibrosis: Molecular signals, cellular mechanisms and translational implications. Mol Aspects Med. 2019;65:2–15.
   PubMed Web of Science ®Google Scholar
• Gressner AM, Weiskirchen R Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-β as major players and therapeutic targets. J Cell Mol Med. 2006;10(1):76–99.
   PubMed Web of Science ®Google Scholar
• Aycock RS, Seyer JM Collagens of normal and cirrhotic human liver. Connect Tissue Res. 1989;23(1):19–31.
   PubMed Web of Science ®Google Scholar
• Abdel-Aziz G, Lebeau G, Rescan PY, et al. Reversibility of hepatic fibrosis in experimentally induced cholestasis in rat. Am J Pathol. 1990;137(6):1333–1342.
   PubMed Web of Science ®Google Scholar
• Martinez-Hernandez A The hepatic extracellular matrix. II. Electron immunohistochemical studies in rats with CCl4-induced cirrhosis. Lab Invest. 1985;53(2):166–186.
   PubMed Web of Science ®Google Scholar
• Martinez-Hernandez A The hepatic extracellular matrix. I. Electron immunohistochemical studies in normal rat liver. Lab Invest. 1984;51(1):57–74.
   PubMed Web of Science ®Google Scholar
• Musso O, Rehn M, Saarela J, et al. Collagen XVIII is localized in sinusoids and basement membrane zones and expressed by hepatocytes and activated stellate cells in fibrotic human liver. Hepatology. 1998;28(1):98–107.
   PubMed Web of Science ®Google Scholar
• Martinez-Hernandez A, Amenta PS The hepatic extracellular matrix. I. Components and distribution in normal liver. Virchows Arch A Pathol Anat Histopathol. 1993;423(1):1–11.
   PubMedGoogle Scholar
• Reid LM, Fiorino AS, Sigal SH, et al. Extracellular matrix gradients in the space of disse: Relevance to liver biology. Hepatology 1992;15(6):1198–1203.
   PubMed Web of Science ®Google Scholar
• Su J, Morgani SM, David CJ, et al. TGF-β orchestrates fibrogenic and developmental EMTs via the RAS effector RREB1. Nature. 2020;577(7791):566–571.
   PubMed Web of Science ®Google Scholar
• Gillis SE, Nagy LE Deposition of cellular fibronectin increases before stellate cell activation in rat liver during ethanol feeding. Alcohol Clin Exp Res. 1997;21(5):857–861.
   PubMed Web of Science ®Google Scholar
• Lo RC, Kim H Histopathological evaluation of liver fibrosis and cirrhosis regression. Clin Mol Hepatol. 2017;23(4):302–307.
   PubMed Web of Science ®Google Scholar
• Sigrist RMS, Liau J, Kaffas AE, et al. Ultrasound elastography: Review of techniques and clinical applications. Theranostics 2017;7(5):1303–1329.
   PubMed Web of Science ®Google Scholar
• Petitclerc L, Gilbert G, Nguyen BN, et al. Liver fibrosis quantification by magnetic resonance imaging. Top Magn Reson Imaging 2017;26(6):229–241.
   PubMedGoogle Scholar
• Li Y, Foss CA, Summerfield DD, et al. Targeting collagen strands by photo-triggered triple-helix hybridization. Proc Natl Acad Sci U S A 2012;109(37):14767–14772.
   PubMed Web of Science ®Google Scholar
• Scherf U, Becker R, Chan M, et al. Approval of novel biomarkers: FDA’s perspective and major requests. Scand J Clin Lab Invest Suppl. 2010;242(sup242):96–102.
   PubMedGoogle Scholar
• Gressner OA, Weiskirchen R, Gressner AM Biomarkers of liver fibrosis: Clinical translation of molecular pathogenesis or based on liver-dependent malfunction tests. Clin Chim Acta. 2007;381(2):107–113.
   PubMed Web of Science ®Google Scholar
• Gressner OA, Weiskirchen R, Gressner AM Biomarkers of hepatic fibrosis, fibrogenesis and genetic pre-disposition pending between fiction and reality. J Cell Mol Med. 2007;11(5):1031–1051.
   PubMed Web of Science ®Google Scholar
• Collazos J, Díaz F Role of the measurement of serum procollagen type III N-terminal peptide in the evaluation of liver diseases. Clin Chim Acta. 1994;227(1–2):37–43.
   PubMed Web of Science ®Google Scholar
• Kadler KE, Baldock C, Bella J, et al. Collagens at a glance. J Cell Sci. 2007;120(Pt 12):1955–1958.
   PubMed Web of Science ®Google Scholar
• Holmes R, Kirk S, Tronci G, et al. Influence of telopeptides on the structural and physical properties of polymeric and monomeric acid-soluble type I collagen. Mater Sci Eng C Mater Biol Appl 2017;77:823–827.
   PubMed Web of Science ®Google Scholar
• Stefanovic B RNA protein interactions governing expression of the most abundant protein in human body, type I collagen. Wiley Interdiscip Rev RNA. 2013;4(5):535–545.
   PubMed Web of Science ®Google Scholar
• Stefanovic B, Hellerbrand C, Holcik M, et al. Posttranscriptional regulation of collagen alpha1(I) mRNA in hepatic stellate cells. Mol Cell Biol. 1997;17(9):5201–5209.
   PubMed Web of Science ®Google Scholar
• Gelse K, Pöschl E, Aigner T Collagens–structure, function, and biosynthesis. Adv Drug Deliv Rev. 2003;55(12):1531–1546.
   PubMed Web of Science ®Google Scholar
• Kramer RZ, Bella J, Mayville P, et al. Sequence dependent conformational variations of collagen triple-helical structure. Nat Struct Biol. 1999;6(5):454–457.
   PubMedGoogle Scholar
• Czaja MJ, Weiner FR, Flanders KC, et al. In vitro and in vivo association of transforming growth factor-β1 with hepatic fibrosis. J Cell Biol. 1989;108(6):2477–2482.
   PubMed Web of Science ®Google Scholar
• Armendariz-Borunda J, Seyer JM, Kang AH, et al. Regulation of TGF β gene expression in rat liver intoxicated with carbon tetrachloride. Faseb J. 1990;4(2):215–221.
   PubMed Web of Science ®Google Scholar
• Dropmann A, Dediulia T, Breitkopf-Heinlein K, et al. TGF-β1 and TGF-β2 abundance in liver diseases of mice and men. Oncotarget 2016;7(15):19499–19518.
   PubMedGoogle Scholar
• Roberts AB, Sporn MB, Assoian RK, et al. Transforming growth factor type beta: Rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci U S A. 1986;83(12):4167–4171.
   PubMed Web of Science ®Google Scholar
• Ignotz RA, Massagué J Transforming growth factor-β stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J Biol Chem. 1986;261(9):4337–4345.
   PubMed Web of Science ®Google Scholar
• Diegelmann RF, Guzelian PS, Gay R, et al. Collagen formation by the hepatocyte in primary monolayer culture and in vivo. Science. 1983;219(4590):1343–1345.
   PubMed Web of Science ®Google Scholar
• Jefferson DM, Reid LM, Giambrone MA, et al. Effects of dexamethasone on albumin and collagen gene expression in primary cultures of adult rat hepatocytes. Hepatology 1985;5(1):14–20.
   PubMed Web of Science ®Google Scholar
• Clement B, Grimaud JA, Campion JP, et al. Cell types involved in collagen and fibronectin production in normal and fibrotic human liver. Hepatology 1986;6(2):225–234.
   PubMed Web of Science ®Google Scholar
• Weiner FR, Czaja MJ, Jefferson DM, et al. The effects of dexamethasone on in vitro collagen gene expression. J Biol Chem. 1987;262(15):6955–6958.
   PubMed Web of Science ®Google Scholar
• Clement B, Laurent M, Guguen-Guillouzo C, et al. Types I and IV procollagen gene expression in cultured rat hepatocytes. Coll Relat Res. 1988;8(4):349–359.
   PubMedGoogle Scholar
• Sudhakaran PR, Stamatoglou SC, Hughes RC Modulation of protein synthesis and secretion by substratum in primary cultures of rat hepatocytes. Exp Cell Res. 1986;167(2):505–516.
   PubMed Web of Science ®Google Scholar
• Geerts A, Geuze HJ, Slot JW, et al. Immunogold localization of procollagen III, fibronectin and heparan sulfate proteoglycan on ultrathin frozen sections of the normal rat liver. Histochemistry. 1986;84(4–6):355–362.
   PubMedGoogle Scholar
• Miyabayashi C, Kojima T, Inoue K, et al. Ultrastructural localization of type IV collagen, laminin and prolyl hydroxylase in biliary epithelial cells of rat liver following ligation of the common bile duct. Gastroenterol Jpn. 1987;22(3):354–369.
   PubMedGoogle Scholar
• Takahara T, Kojima T, Miyabayashi C, et al. Collagen production in fat-storing cells after carbon tetrachloride intoxication in the rat. Immunoelectron microscopic observation of type I, type III collagens, and prolyl hydroxylase. Lab Invest. 1988;59(4):509–521.
   PubMed Web of Science ®Google Scholar
• Maher JJ, McGuire RF Extracellular matrix gene expression increases preferentially in rat lipocytes and sinusoidal endothelial cells during hepatic fibrosis in vivo. J Clin Invest. 1990; 86(5):1641–1648.
   PubMed Web of Science ®Google Scholar
• Rossmanith W, Schulte-Hermann R Biology of transforming growth factor β in hepatocarcinogenesis. Microsc Res Tech. 2001;52(4):430–436.
   PubMed Web of Science ®Google Scholar
• Date M, Matsuzaki K, Matsushita M, et al. Differential expression of transforming growth factor-β and its receptors in hepatocytes and nonparenchymal cells of rat liver after CCl4 administration. J Hepatol. 1998;28(4):572–581.
   PubMed Web of Science ®Google Scholar
• Date M, Matsuzaki K, Matsushita M, et al. Modulation of transforming growth factor beta function in hepatocytes and hepatic stellate cells in rat liver injury. Gut 2000;46(5):719–724.
   PubMed Web of Science ®Google Scholar
• DeLeve LD Liver sinusoidal endothelial cells in hepatic fibrosis. Hepatology 2015;61(5):1740–1746.
   PubMed Web of Science ®Google Scholar
• Natarajan V, Harris EN, Kidambi S SECs (sinusoidal endothelial cells), liver microenvironment, and fibrosis. Biomed Res Int 2017;2017:4097205.
   PubMed Web of Science ®Google Scholar
• Braet F, Wisse E Structural and functional aspects of liver sinusoidal endothelial cell fenestrae: A review. Comp Hepatol. 2002;1(1):1
   PubMedGoogle Scholar
• Bedossa P, Paradis V Liver extracellular matrix in health and disease. J Pathol. 2003;200(4):504–515.
   PubMed Web of Science ®Google Scholar
• McGuire RF, Bissell DM, Boyles J, et al. Role of extracellular matrix in regulating fenestrations of sinusoidal endothelial cells isolated from normal rat liver. Hepatology. 1992;15(6):989–997.
   PubMed Web of Science ®Google Scholar
• Marrone G, Shah VH, Gracia-Sancho J Sinusoidal communication in liver fibrosis and regeneration. J Hepatol. 2016;65(3):608–617.
   PubMed Web of Science ®Google Scholar
• Irving MG, Roll FJ, Huang S, et al. Characterization and culture of sinusoidal endothelium from normal rat liver: Lipoprotein uptake and collagen phenotype. Gastroenterology 1984;87(6):1233–1247.
   PubMed Web of Science ®Google Scholar
• Neubauer K, Krüger M, Quondamatteo F, et al. Transforming growth factor-β1 stimulates the synthesis of basement membrane proteins laminin, collagen type IV and entactin in rat liver sinusoidal endothelial cells. J Hepatol. 1999;31(4):692–702.
   PubMed Web of Science ®Google Scholar
• Schuppan D, Ashfaq-Khan M, Yang AT, et al. Liver fibrosis: Direct antifibrotic agents and targeted therapies. Matrix Biol. 2018;68-69:435–451.
   PubMed Web of Science ®Google Scholar
• Malizia G, Brunt EM, Peters MG, et al. Growth factor and procollagen type I gene expression in human liver disease. Gastroenterology 1995;108(1):145–156.
   PubMed Web of Science ®Google Scholar
• Sato Y, Harada K, Ozaki S, et al. Cholangiocytes with mesenchymal features contribute to progressive hepatic fibrosis of the polycystic kidney rat. Am J Pathol. 2007;171(6):1859–1871.
   PubMed Web of Science ®Google Scholar
• Liu J, Eischeid AN, Chen XM Col1A1 production and apoptotic resistance in TGF-β1-induced epithelial-to-mesenchymal transition-like phenotype of 603B cells. PLoS One. 2012;7(12):e51371.
   PubMed Web of Science ®Google Scholar
• Milani S, Herbst H, Schuppan D, et al. Transforming growth factors β1 and β2 are differentially expressed in fibrotic liver disease. Am J Pathol. 1991;139(6):1221–1229.
   PubMed Web of Science ®Google Scholar
• Dropmann A, Dooley S, Dewidar B, et al. TGF-β2 silencing to target biliary-derived liver diseases. Gut 2020;69(9):1677–1690.
   PubMed Web of Science ®Google Scholar
• Senoo H, Mezaki Y, Fujiwara M The stellate cell system (vitamin A-storing cell system). Anat Sci Int. 2017;92(4):387–455.
   PubMed Web of Science ®Google Scholar
• Davis BH Transforming growth factor beta responsiveness is modulated by the extracellular collagen matrix during hepatic ito cell culture. J Cell Physiol. 1988;136(3):547–553.
   PubMed Web of Science ®Google Scholar
• Bataller R, Brenner DA Liver fibrosis. J Clin Invest. 2005;115(2):209–218.
   PubMed Web of Science ®Google Scholar
• Kisseleva T, Cong M, Paik Y, et al. Myofibroblasts revert to an inactive phenotype during regression of liver fibrosis. Proc Natl Acad Sci U S A. 2012;109(24):9448–9453.
   PubMed Web of Science ®Google Scholar
• Tang L, Tanaka Y, Marumo F, et al. Phenotypic change in portal fibroblasts in biliary fibrosis. Liver. 1994;14(2):76–82.
   PubMedGoogle Scholar
• Tuchweber B, Desmoulière A, Bochaton-Piallat ML, et al. Proliferation and phenotypic modulation of portal fibroblasts in the early stages of cholestatic fibrosis in the rat. Lab Invest. 1996;74(1):265–278.
   PubMed Web of Science ®Google Scholar
• Dranoff JA, Wells RG Portal fibroblasts: Underappreciated mediators of biliary fibrosis. Hepatology. 2010;51(4):1438–1444.
   PubMed Web of Science ®Google Scholar
• Iwaisako K, Jiang C, Zhang M, et al. Origin of myofibroblasts in the fibrotic liver in mice. Proc Natl Acad Sci U S A. 2014;111(32):E3297–305.
   PubMed Web of Science ®Google Scholar
• Nishio T, Hu R, Koyama Y, et al. Activated hepatic stellate cells and portal fibroblasts contribute to cholestatic liver fibrosis in MDR2 knockout mice. J Hepatol. 2019;71(3):573–585.
   PubMed Web of Science ®Google Scholar
• Senoo H, Hata R, Nagai Y, et al. Stellate cells (vitamin a-storing cells) are the primary site of collagen synthesis in non-parenchymal cells in the liver. Biomed Res 1984;5(6):451–458.
   Web of Science ®Google Scholar
• Seo HY, Lee SH, Lee JH, et al. Src inhibition attenuates liver fibrosis by preventing hepatic stellate cell activation and decreasing connetive tissue growth factor. Cells 2020;9(3). pii: E558.
   Web of Science ®Google Scholar
• Chiaramonte MG, Cheever AW, Malley JD, et al. Studies of murine schistosomiasis reveal interleukin-13 blockade as a treatment for established and progressive liver fibrosis. Hepatology 2001;34(2):273–282.
   PubMed Web of Science ®Google Scholar
• Kurioka A, Walker LJ, Klenerman P, et al. MAIT cells: New guardians of the liver. Clin transl immunology 2016;5(8):e98. Erratum in: Clin Transl Immunology 2017;6(2):e132.
   PubMedGoogle Scholar
• Fabre T, Molina MF, Soucy G, et al. Type 3 cytokines IL-17A and IL-22 drive TGF-β-dependent liver fibrosis. Sci Immunol. 2018;3(28). pii: eaar7754.
   PubMed Web of Science ®Google Scholar
• Meng F, Wang K, Aoyama T, et al. Interleukin-17 signaling in inflammatory, Kupffer cells, and hepatic stellate cells exacerbates liver fibrosis in mice. Gastroenterology 2012;143(3):765–776.e3.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Lin C, Peng L, et al. High mobility group box 1 activates Toll like receptor 4 signaling in hepatic stellate cells. Life Sci. 2012;91(5–6):207–212.
   PubMed Web of Science ®Google Scholar
• Ge WS, Wu JX, Fan JG, et al. Inhibition of high-mobility group box 1 expression by siRNA in rat hepatic stellate cells. World J Gastroenterol. 2011;17(36):4090–4098.
   PubMed Web of Science ®Google Scholar
• El Mourabit H, Loeuillard E, Lemoinne S, et al. Culture model of rat portal myofibroblasts. Front Physiol 2016;7:120.
   PubMed Web of Science ®Google Scholar
• Lemoinne S, Cadoret A, Rautou P-E, et al. Portal myofibroblasts promote vascular remodeling underlying cirrhosis formation through the release of microparticles. Hepatology 2015;61(3):1041–1055.
   PubMed Web of Science ®Google Scholar
• Jabłońska-Trypuć A, Matejczyk M, Rosochacki S Matrix metalloproteinases (MMPs), the main extracellular matrix (ECM) enzymes in collagen degradation, as a target for anticancer drugs. J Enzyme Inhib Med Chem. 2016;31(sup1):177–183.
   PubMed Web of Science ®Google Scholar
• Roeb E Matrix metalloproteinases and liver fibrosis (translational aspects). Matrix Biol. 2018;68-69:463–473.
   PubMed Web of Science ®Google Scholar
• Iimuro Y, Nishio T, Morimoto T, et al. Delivery of matrix metalloproteinase-1 attenuates established liver fibrosis in the rat. Gastroenterology 2003;124(2):445–458.
   PubMed Web of Science ®Google Scholar
• Zhou X, Murphy FR, Gehdu N, et al. Engagement of αvβ3 integrin regulates proliferation and apoptosis of hepatic stellate cells. J Biol Chem. 2004;279(23):23996–24006.
   PubMed Web of Science ®Google Scholar
• Hartland SN, Murphy F, Aucott RL, et al. Active matrix metalloproteinase-2 promotes apoptosis of hepatic stellate cells via the cleavage of cellular N-cadherin. Liver Int. 2009;29(7):966–978.
   PubMed Web of Science ®Google Scholar
• Roderfeld M, Weiskirchen R, Wagner S, et al. Inhibition of hepatic fibrogenesis by matrix metalloproteinase-9 mutants in mice. Faseb J. 2006;20(3):444–454.
   PubMed Web of Science ®Google Scholar
• Ricard-Blum S The collagen family. Cold Spring Harb Perspect Biol 2011;3(1): a004978.
   PubMed Web of Science ®Google Scholar
• Karsdal MA, Daniels SJ, Holm Nielsen S, et al. Collagen biology and non-invasive biomarkers of liver fibrosis. Liver Int. 2020;40(4):736–750.
   PubMed Web of Science ®Google Scholar
• Karsdal MA, Nielsen SH, Leeming DJ, et al. The good and the bad collagens of fibrosis - Their role in signaling and organ function. Adv Drug Deliv Rev 2017;121:43–56.
   PubMed Web of Science ®Google Scholar
• Villesen IF, Daniels SJ, Leeming DJ, et al. Review article: The signalling and functional role of the extracellular matrix in the development of liver fibrosis. Aliment Pharmacol Ther 2020;52(1):85–97.
   PubMed Web of Science ®Google Scholar
• Karsdal MA, Detlefsen S, Daniels SJ, et al. Is the total amount as important as localization and type of collagen in liver fibrosis attributable to steatohepatitis? Hepatology. 2020;71(1):346–351.
   PubMed Web of Science ®Google Scholar
• Manon-Jensen T, Kjeld NG, Karsdal MA Collagen-mediated hemostasis. J Thromb Haemost 2016;14(3):438–448.
   PubMed Web of Science ®Google Scholar
• Karsdal MA, Leeming DJ, Henriksen K, et al. Biochemistry of Collagens, Laminins and Elastin: structure, function and biomarkers. Second edition. Academic press. Elsevier, 2019 ISBN: 978–0–12–817068–7
   Google Scholar
• Karsdal MA, Detlefsen S, Daniels SJ, et al. Is the total amount as important as localization and type of collagen in liver fibrosis attributable to steatohepatitis? Hepatology 2019;71(1):346–351.
   PubMed Web of Science ®Google Scholar
• Park J, Scherer PE Endotrophin - a novel factor linking obesity with aggressive tumor growth. Oncotarget 2012;3(12):1487–1488.
   PubMedGoogle Scholar
• Karsdal MA, Henriksen K, Nielsen MJ, et al. Fibrogenesis assessed by serological type III collagen formation identifies patients with progressive liver fibrosis and responders to a potential antifibrotic therapy. Am J Physiol Gastrointest Liver Physiol 2016;311(6):G1009–G1017.
   PubMed Web of Science ®Google Scholar
• Nielsen MJ, Villesen IF, Gudmann NS, et al. Serum markers of type III and IV procollagen processing predict recurrence of fibrosis in liver transplanted patients. Sci Rep 2019;9(1):14857.
   PubMedGoogle Scholar
• Nielsen MJ, Thorburn D, Lemming DJ, et al. Serological biomarkers of extracellular matrix remodeling predict transplant-free survival in primary sclerosing cholangitis patients. J Hepatol 2016;64(2):S199.
   PubMedGoogle Scholar
• Almpanis Z, Demonakou M, Tiniakos D Evaluation of liver fibrosis: “Something old, something new … ”. Ann Gastroenterol. 2016;29(4):445–453.
   PubMed Web of Science ®Google Scholar
• Sweat F, Puchtler H, Rosenthal SI Sirius Red F3BA as a stain for connective tissue. Arch Pathol. 1964;78:69–72.
   PubMedGoogle Scholar
• Puchtler H, Waldrop FS, Valentine LS Fluorescence microscopic distinction between elastin and collagen. Histochemie. 1973;35(1):17–30.
   PubMedGoogle Scholar
• Junquiera LC, Junqueira LC, Brentani RR A simple and sensitive method for the quantitative estimation of collagen. Anal Biochem. 1979;94(1):96–99.
   PubMed Web of Science ®Google Scholar
• Rittié L Method for picrosirius red-polarization detection of collagen fibers in tissue sections. Methods Mol Biol 2017;1627:395–407.
   PubMedGoogle Scholar
• Piccinin MA, Schwartz J. Histology, Verhoeff Stain. 2018 Oct 27. StatPearls . Treasure Island (FL): StatPearls Publishing; 2020 Jan. cited 2020 Aug 4. Available from: http://www.ncbi.nlm.nih.gov/books/NBK519050/
   Google Scholar
• Sheehan DC, Hrapchak BB. Theory and practice of histotechnology. Columbus (OH): Battelle Press; 1987. ISBN: 978–1574770674
   Google Scholar
• Bancroft J, Gamble M Theory and practice of histological techniques. 6th Edition. Churchill-Livingstone, London 2008. ISBN: 978–0443102790
   Google Scholar
• Rappu P, Salo AM, Myllyharju J, et al. Role of prolyl hydroxylation in the molecular interactions of collagens. Essays Biochem. 2019;63(3):325–335.
   PubMed Web of Science ®Google Scholar
• Sipilä KH, Drushinin K, Rappu P, et al. Proline hydroxylation in collagen supports integrin binding by two distinct mechanisms. J Biol Chem. 2018;293(20):7645–7658.
   PubMed Web of Science ®Google Scholar
• Cundy T, Reid IR, Grey A CHAPTER 31 - Metabolic bone disease. In: Clinical biochemistry: metabolic and clinical aspects. 3rd Edition 2014. (Eds: Marshall WJ, Marta L, Day AP, et al.), Churchill Livingstone, Elsevier. p. 604–635. ISBN: 9780702051401.
   Google Scholar
• Cissell DD, Link JM, Hu JC, et al. A modified hydroxyproline assay based on hydrochloric acid in Ehrlich’s solution accurately measures tissue collagen content. Tissue Eng Part C Methods 2017;23(4):243–250.
   PubMed Web of Science ®Google Scholar
• Neuman RE, Logan MA The determination of hydroxyproline. J Biol Chem 1950;184(1):299–306.
   PubMed Web of Science ®Google Scholar
• Stoilov I, Starcher BC, Mecham RP, et al. Measurement of elastin, collagen, and total protein levels in tissues. Methods Cell Biol. 2018;143:133–146.
   PubMed Web of Science ®Google Scholar
• Li S, Sun X, Chen M, et al. Liver fibrosis conventional and molecular imaging diagnosis update. J Liver 2019;8(1).pii: 236.
   PubMedGoogle Scholar
• Hwang J, Huang Y, Burwell TJ, et al. In situ imaging of tissue remodeling with collagen hybridizing peptides. ACS Nano 2017;11(10):9825–9835.
   PubMed Web of Science ®Google Scholar
• Zheng L, Ding X, Liu K, et al. Molecular imaging of fibrosis using a novel collagen-binding peptide labelled with (99m)Tc on SPECT/CT. Amino Acids 2017;49(1):89–101.
   PubMed Web of Science ®Google Scholar
• Henriksen K, Bollerslev J, Everts V, et al. Osteoclast activity and subtypes as a function of physiology and pathology–implications for future treatments of osteoporosis. Endocr Rev 2011;32:31–63.
   PubMed Web of Science ®Google Scholar
• Karsdal MA, Henriksen K, Bay-Jensen AC Biochemical markers in osteoarthritis with lessons learned from osteoporosis. Clin Exp Rheumatol 2019;37 (Suppl 1), 73–87.
   Google Scholar
• Leeming D, Larsen D, Zhang C, et al. Enzyme-linked immunosorbent serum assays (ELISAs) for rat and human N-terminal pro-peptide of collagen type I (PINP) – assessment of corresponding epitopes. Clin Biochem 2010;43:1249–1256. 15
   PubMed Web of Science ®Google Scholar
• Gudmann NS, Munk HL, Christensen AF, et al. Chondrocyte activity is increased in psoriatic arthritis and axial spondyloarthritis. Arthritis Res Ther 2016;18(1):141.
   PubMedGoogle Scholar
• Schuppan D, Besser M, Schwarting R, et al. Radioimmunoassay for the carboxy-terminal cross-linking domain of type IV (basement membrane) procollagen in body fluids. Characterization and application to collagen type IV metabolism in fibrotic liver disease. J Clin Invest. 1986;78(1):241–248.
   PubMed Web of Science ®Google Scholar
• Henriksen NA, Mortensen JH, Sorensen LT, et al. The collagen turnover profile is altered in patients with inguinal and incisional hernia. Surgery 2015;157(2):312–321.
   PubMed Web of Science ®Google Scholar
• Karsdal MA, Henriksen K, Genovese F, et al. Serum endotrophin identifies optimal responders to PPARγ agonists in type 2 diabetes. Diabetologia 2017;60(1):50–59.
   PubMed Web of Science ®Google Scholar
• Hansen NU, Willumsen N, Sand JM, et al. Type VIII collagen is elevated in diseases associated with angiogenesis and vascular remodeling. Clin Biochem 2016;49(12):903–908.
   PubMed Web of Science ®Google Scholar
• He Y, Siebuhr AS, Brandt-Hansen NU, et al. Type X collagen levels are elevated in serum from human osteoarthritis patients and associated with biomarkers of cartilage degradation and inflammation. BMC Musculoskelet Disord 2014;15(1):309.
   PubMedGoogle Scholar
• Rosenquist C, Fledelius C, Christgau S, et al. Serum CrossLaps One Step ELISA. First application of monoclonal antibodies for measurement in serum of bone-related degradation products from C-terminal telopeptides of type I collagen. Clin Chem.1998; 44(11):2281–2289.
   PubMed Web of Science ®Google Scholar
• Guañabens N, Parés A, Alvarez L, et al. Collagen-related markers of bone turnover reflect the severity of liver fibrosis in patients with primary biliary cirrhosis. J Bone Miner Res. 1998;13(4):731–738.
   PubMed Web of Science ®Google Scholar
• Bay-Jensen AC, Leeming D, Kleyer A, et al. Ankylosing spondylitis is characterized by an increased turnover of several different metalloproteinase-derived collagen species: A cross-sectional study. Rheumatol Int 2012;32(11):3565–3572.
   PubMed Web of Science ®Google Scholar
• Barascuk N, Veidal SS, Larsen L, et al. A novel assay for extracellular matrix remodeling associated with liver fibrosis: An enzyme-linked immunosorbent assay (ELISA) for a MMP-9 proteolytically revealed neo-epitope of type III collagen. Clin.Biochem. 2010;43(10–11): 899–904.
   PubMed Web of Science ®Google Scholar
• Leeming DJ, Sand JM, Nielsen MJ, et al. Serological investigation of the collagen degradation profile of patients with chronic obstructive pulmonary disease or idiopathic pulmonary fibrosis. Biomark.Insights. 2012;7:119–126.
   PubMedGoogle Scholar
• Nielsen SH, Willumsen N, Brix S, et al. Tumstatin, a matrikine derived from collagen type IVα3, is elevated in serum from patients with non–small cell lung cancer. Transl Oncol 2018;11(2):528–534.
   PubMed Web of Science ®Google Scholar
• Sun S, Henriksen K, Karsdal MA, et al. Collagen type III and VI turnover in response to long-term immobilization. PLoS One 2015;10(12):e0144525.
   PubMed Web of Science ®Google Scholar
• Bager CL, Willumsen N, Christiansen C, et al. Bone and soft tissue turnover in relation to all-cause mortality in postmenopausal women. J Gerontol A Biol Sci Med Sci. 2019;74(7):1098–1104.
   PubMed Web of Science ®Google Scholar
• Veidal SS, Vassiliadis E, Bay-Jensen AC, et al. Procollagen type I N-terminal propeptide (PINP) is a marker for fibrogenesis in bile duct ligation-induced fibrosis in rats. Fibrogenesis Tissue Repair 2010;3(1),5.
   PubMedGoogle Scholar
• Leeming DJ, Byrjalsen I, Jimenez W, et al. Protein fingerprinting of the extracellular matrix remodelling in a rat model of liver fibrosis–a serological evaluation. Liver Int 2013;33(3):439–447.
   PubMed Web of Science ®Google Scholar
• Bentsen KD, Horn T, Risteli J, et al. Serum aminoterminal type III procollagen peptide and the 7S domain of type IV collagen in patients with alcohol abuse. Relation to ultrastructural fibrosis in the acinar zone 3 and to serum hyaluronan. Liver. 1987;7(6):339–346.
   PubMedGoogle Scholar
• Cho JJ, Lee YS Enzyme-linked immunosorbent assay for serum procollagen type III peptide in rats with hepatic fibrosis. J Vet Med Sci. 1998;60(11):1213–1220.
   PubMed Web of Science ®Google Scholar
• Leeming DJ, Nielsen MJ, Dai Y, et al. Enzyme-linked immunosorbent serum assay specific for the 7S domain of Collagen Type IV (P4NP 7S): A marker related to the extracellular matrix remodeling during liver fibrogenesis. Hepatol Res 2012;42(5):482–493.
   PubMed Web of Science ®Google Scholar
• Färkkilä M, Rautiainen H, Kärkkäinen P, et al. Serological markers for monitoring disease progression in noncirrhotic primary biliary cirrhosis on ursodeoxycholic acid therapy. Liver Int. 2008;28(6):787–797.
   PubMed Web of Science ®Google Scholar
• Lieber CS, Weiss DG, Paronetto F; Veterans Affairs Cooperative Study 391 Group. Value of fibrosis markers for staging liver fibrosis in patients with precirrhotic alcoholic liver disease. Alcohol Clin Exp Res. 2008;32(6):1031–1039.
   PubMed Web of Science ®Google Scholar
• Nielsen MJ, Veidal SS, Karsdal MA, et al. Plasma Pro-C3 (N-terminal type III collagen propeptide) predicts fibrosis progression in patients with chronic hepatitis C. Liver Int 2015;35(2):429–437.
   PubMed Web of Science ®Google Scholar
• Nielsen MJ, Kazankov K, Leeming DJ, et al. Markers of collagen remodeling detect clinically significant fibrosis in chronic hepatitis C patients. PLoS One 2015;10(9):e0137302.
   PubMed Web of Science ®Google Scholar
• Caussy C, Bhargava M, Villesen IF, et al. Collagen formation assessed by N-terminal propeptide of type 3 procollagen is a heritable trait and is associated with liver fibrosis assessed by magnetic resonance elastography. Hepatology 2019;70(1):127–141.
   PubMed Web of Science ®Google Scholar
• Leeming D, He Y, Veidal SS, et al. A novel marker for assessment of liver matrix remodeling: An enzyme-linked immunosorbent assay (ELISA) detecting a MMP generated type I collagen neo-epitope (C1M). Biomarkers 2011;16(7):616–628.
   PubMed Web of Science ®Google Scholar
• Stickel F, Urbaschek R, Schuppan D, et al. Serum collagen type VI and XIV and hyaluronic acid as early indicators for altered connective tissue turnover in alcoholic liver disease. Dig Dis Sci. 2001;46(9):2025–2032.
   PubMed Web of Science ®Google Scholar
• Weiskirchen R, Tacke F The role of radiologic modalities in diagnosing nonalcoholic steatohepatitis (NASH) and fibrosis. Curr Hepatol Rep (2018) 17(4):324–335.
   Google Scholar
• Fernandes FF, Ferraz ML, Andrade LE, et al. Enhanced liver fibrosis panel as a predictor of liver fibrosis in chronic hepatitis C patients. J Clin Gastroenterol 2015;49(3):235–241.
   PubMed Web of Science ®Google Scholar
• Day J, Patel P, Parkes J, et al. Derivation and performance of standardized enhanced liver fibrosis (ELF) test thresholds for the detection and prognosis of liver fibrosis. J Appl Lab Med. 2019;3(5):815–826.
   PubMedGoogle Scholar
• Tien PC, Duarte M, Roque A, et al. MRE and ELF in liver fibrosis assessment: Are two better than one? Dig Dis Sci. 2019;65(4):928–930.
   Web of Science ®Google Scholar
• Lichtinghagen R, Pietsch D, Bantel H, et al. The Enhanced Liver Fibrosis (ELF) score: Normal values, influence factors and proposed cut-off values. J Hepatol 2013;59(2):236–242.
   PubMed Web of Science ®Google Scholar
• Jabor A, Kubíček Z, Fraňková S, et al. Enhanced liver fibrosis (ELF) score: Reference ranges, biological variation in healthy subjects, and analytical considerations. Clin Chim Acta 2018;483:291–295.
   PubMed Web of Science ®Google Scholar
• Siemens Healthineers. Physician brochure for ELF blood test and the relation to liver fibrosis. cited 2020 Aug 4. Download at: https://static.healthcare.siemens.com/siemens_hwem-hwem_ssxa_websites-context-root/wcm/idc/groups/public/@global/documents/download/mda2/nda1/~edisp/elf_physician_brochure_a91dx-160435-xc1-4a00_final-03470658.pdf
   Google Scholar
• Patel K, Sebastiani G Limitations of non-invasive tests for assessment of liver fibrosis. JHEP Rep. 2020;2(2):100067.
   PubMedGoogle Scholar
• Rosenberg WM, Voelker M, Thiel R, et al. Serum markers detect the presence of liver fibrosis: A cohort study. Gastroenterology 2004;127(6):1704–1713.
   PubMed Web of Science ®Google Scholar
• Staufer K, Halilbasic E, Spindelboeck W, et al. Evaluation and comparison of six noninvasive tests for prediction of significant or advanced fibrosis in nonalcoholic fatty liver disease. United Eur Gastroenterol J 2019;7(8):1113–1123.
   PubMed Web of Science ®Google Scholar
• Inadomi C, Takahashi H, Ogawa Y, et al. Accuracy of the enhanced liver fibrosis test and combination of the Enhanced liver fibrosis and noninvasive tests for the diagnosis of advanced liver fibrosis in patients with non-alcoholic fatty liver disease. Hepatol Res. 2020;50(6):682–692.
   PubMed Web of Science ®Google Scholar
• Nobili V, Parkes J, Bottazzo G, et al. Performance of ELF serum markers in predicting fibrosis stage in pediatric non-alcoholic fatty liver disease. Gastroenterology 2009;136(1):160–167.
   PubMed Web of Science ®Google Scholar
• Guha IN, Parkes J, Roderick P, et al. Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: Validating the European Liver Fibrosis Panel and exploring simple markers. Hepatology 2008;47(2):455–460.
   PubMed Web of Science ®Google Scholar
• Thiele M, Madsen BS, Hansen JF, et al. Accuracy of the enhanced liver fibrosis test vs FibroTest, elastography, and indirect markers in detection of advanced fibrosis in patients with alcoholic liver disease. Gastroenterology 2018;154(5):1369–1379.
   PubMed Web of Science ®Google Scholar
• Asphaug L, Thiele M, Krag A, et al. Cost-effectiveness of noninvasive screening for alcohol-related liver fibrosis. Hepatology 2020;71(6):2093–2104.
   PubMed Web of Science ®Google Scholar
• Anstee QM, Lawitz EJ, Alkhouri N, et al. Noninvasive tests accurately identify advanced fibrosis due to NASH: Baseline data from the STELLAR trials. Hepatology 2019;70(5):1521–1530.
   PubMed Web of Science ®Google Scholar
• Saffioti F, Roccarina D, Vesterhus M, et al. Cholangiocarcinoma is associated with a raised enhanced liver fibrosis score independent of primary sclerosing cholangitis. Eur J Clin Invest. 2019;49(5):e13088.
   PubMed Web of Science ®Google Scholar
• Parkes J, Guha IN, Roderick P, et al. Enhanced Liver Fibrosis (ELF) test accurately identifies liver fibrosis in patients with chronic hepatitis C. J Viral Hepat. 2011;18(1):23–31.
   PubMed Web of Science ®Google Scholar
• Cobbold JF, Crossey MM, Colman P, et al. Optimal combinations of ultrasound-based and serum markers of disease severity in patients with chronic hepatitis C. J Viral Hepat. 2010;17(8):537–545.
   PubMed Web of Science ®Google Scholar
• Liang LY, Wong VW, Tse YK, et al. Improvement in enhanced liver fibrosis score and liver stiffness measurement reflects lower risk of hepatocellular carcinoma. Aliment Pharmacol Ther. 2019;49(12):1509–1517.
   PubMed Web of Science ®Google Scholar
• Heo JY, Kim BK, Park JY, et al. Combination of transient elastography and an enhanced liver fibrosis test to assess the degree of liver fibrosis in patients with chronic hepatitis B. Gut Liver 2018;12(2):190–200.
   PubMed Web of Science ®Google Scholar
• Kawashiri SY, Origuchi T, Umeda M, et al. Association of serum levels of fibrosis-related biomarkers with disease activity in patients with IgG4-related disease. Arthritis Res Ther. 2018;20(1):277.
   PubMedGoogle Scholar
• Cai P, Mu Y, Olveda RM, et al. Circulating miRNAs as footprints for liver fibrosis grading in schistosomiasis. EBioMedicine 2018;37:334–343.
   PubMed Web of Science ®Google Scholar
• Janciauskiene S, Wallmark A, Piitulainen E, et al. Performance of enhanced liver fibrosis plasma markers in asymptomatic individuals with ZZ α1-antitrypsin deficiency. Eur J Gastroenterol Hepatol. 2011;23(8):716–720.
   PubMed Web of Science ®Google Scholar
• Attallah AM, Omran D, Omran MM, et al. Fibro-Mark: A panel of laboratory parameters for predicting significant fibrosis in chronic hepatitis C patients. Br J Biomed Sci. 2018;75(1):19–23.
   PubMed Web of Science ®Google Scholar
• Bekki Y, Yoshizumi T, Shimoda S, et al. Hepatic stellate cells secreting WFA+-M2BP: Its role in biological interactions with Kupffer cells. J Gastroenterol Hepatol. 2017;32(7):1387–1393.
   PubMed Web of Science ®Google Scholar